Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 11 de 11
Filter
1.
Neuroscience ; 275: 352-64, 2014 Sep 05.
Article in English | MEDLINE | ID: mdl-24956283

ABSTRACT

The murine genes encoding transthyretin (TTR) and retinol binding protein (RBP) were independently silenced by targeted disruption more than 10 years ago. Studies of both strains showed surprisingly little impact on either thyroid function or retinoid metabolism. Silencing TTR led to a relatively mild behavioral phenotype. In order to gain insight into the behavioral effect and determine if it was related to TTR's function as the carrier of RBP we carried out simultaneous studies with homozygous Rbp4(-/-) and Ttr(-/-) animals 4-7 months of age. Both strains showed behavioral differences relative to Ttr and Rbp4 wild-type animals and each other. The patterns were discrete for each knockout although there was some overlap. Neuropathologic examination of the cortex and hippocampus revealed cortical and hippocampal (CA3) neuronal loss in both and some degree of gliosis, more pronounced in the Rbp4(-/-) mice. There also appeared to be a major reduction in proliferating neuroblasts in the subventricular zone in both strains, which was also more severe in the Rbp4(-/-) mice. This is the first description of behavioral abnormalities in Rbp4(-/-)mice. The data also indicate that it is unlikely that the behaviors seen in Ttr(-/-) mice are related to its function as an RBP carrier.


Subject(s)
Behavior, Animal/physiology , Brain/pathology , Prealbumin/metabolism , Retinol-Binding Proteins/deficiency , Animals , Blotting, Western , Brain/physiopathology , Mice , Mice, 129 Strain , Mice, Inbred C57BL , Mice, Knockout , Prealbumin/deficiency
2.
Cell Death Dis ; 2: e120, 2011 Feb 10.
Article in English | MEDLINE | ID: mdl-21368891

ABSTRACT

Recent studies show that in Alzheimer's disease (AD), alterations in neurogenesis contribute to the neurodegenerative process. Neurodegeneration in AD has been associated with aberrant signaling through the cyclin-dependent kinase-5 (CDK5) pathway via its activators p35/p25; however, the role of CDK5 in the mechanisms of defective adult neurogenesis in AD is unknown. First, to study AD-like abnormal activation of CDK5 signaling in an in vitro model of neurogenesis, neuronal progenitor cells (NPCs) were infected with a viral vector expressing p35, and exposed to amyloid-ß protein (Aß(1-42)). These conditions resulted in impaired maturation and neurite outgrowth in vitro, and these effects were reversed by pharmacological or genetic inhibition of CDK5. Similarly, neurogenesis was impaired in a transgenic mouse model of AD that expresses high levels of amyloid precursor protein (APP), and this effect was reversed in transgenic mice crossed with a CDK5 heterozygous-deficient mouse line. A similar rescue effect was observed in APP transgenic mice treated with Roscovitine, a pharmacological inhibitor of CDK5. Taken together, these data suggest that the CDK5 signaling pathway has a critical role in maintaining the integrity of NPCs and neuronal maturation in the adult hippocampus. Moreover, potential therapeutic approaches could focus on modulating the aberrant activity of CDK5 to target the neurogenic and neurodegenerative alterations in AD.


Subject(s)
Alzheimer Disease/enzymology , Cyclin-Dependent Kinase 5/metabolism , Neurogenesis , Neurons/cytology , Signal Transduction , Alzheimer Disease/genetics , Alzheimer Disease/metabolism , Alzheimer Disease/physiopathology , Amyloid beta-Peptides/genetics , Amyloid beta-Peptides/metabolism , Animals , Cyclin-Dependent Kinase 5/genetics , Disease Models, Animal , Female , Hippocampus/cytology , Hippocampus/enzymology , Hippocampus/metabolism , Humans , Male , Mice , Mice, Transgenic , Neurons/enzymology , Neurons/metabolism , Rats , Stem Cells/cytology , Stem Cells/enzymology , Stem Cells/metabolism
3.
Neuroscience ; 169(1): 488-94, 2010 Aug 11.
Article in English | MEDLINE | ID: mdl-20433905

ABSTRACT

The cognitive impairment in Alzheimer's disease (AD) is associated with synaptic loss, neuritic sprouting and altered neuroplasticity. Compensatory neuritic sprouting might be beneficial, while aberrant sprouting could contribute to the neurodegenerative process. Nogo (or Rtn4) is a major myelin-derived inhibitor of axonal sprouting in adult CNS. Recent evidence has implicated both the Reticulon family of proteins and a receptor for Nogo, NgR, in reducing amyloid-beta production, a key step in AD pathogenesis. To test the hypothesis that Nogo, as an inhibitor of axonal sprouting, modulates disease progression in a mouse model of AD, we introduced an APP transgene (a human APP minigene carrying the Swedish and Indiana mutations under the platelet-derived growth factor subunit B (PDGFB) promoter) into a Nogo null background and characterized the behavioral and neuropathological consequences. We found that deleting Nogo ameliorates learning and memory deficits of APP transgenic mice in the Morris water maze at an early/intermediate stage of the disease. Furthermore, deleting Nogo restored the expression levels of markers for synapto-dendritic complexity and axonal sprouting including synaptophysin, MAP2, GAP43 and neurofilament that are otherwise reduced in APP transgenic mice. Other aspects of disease progression including neuronal loss, astrogliosis, microgliosis and, importantly, Abeta levels and amyloid deposits were not significantly altered by Nogo deletion. These data support the hypothesis that Nogo-mediated inhibition of neuritic sprouting contributes to the disease progression in an APP transgenic model of AD in a way that is mechanistically distinct from what has been proposed for Rtn3 or NgR.


Subject(s)
Alzheimer Disease/genetics , Amyloid beta-Protein Precursor/genetics , Brain/pathology , Myelin Proteins/deficiency , Alzheimer Disease/pathology , Alzheimer Disease/prevention & control , Amyloid beta-Protein Precursor/physiology , Amyloid beta-Protein Precursor/toxicity , Animals , Crosses, Genetic , Dentate Gyrus/chemistry , Dentate Gyrus/pathology , Disease Models, Animal , Disease Progression , Frontal Lobe/pathology , Gliosis/etiology , Gliosis/pathology , Humans , Maze Learning , Mice , Mice, Inbred C57BL , Mice, Inbred DBA , Mice, Knockout , Mice, Transgenic , Myelin Proteins/genetics , Myelin Proteins/physiology , Nerve Tissue Proteins/analysis , Neurites/ultrastructure , Nogo Proteins , Plaque, Amyloid/pathology , Point Mutation , Recombinant Fusion Proteins/genetics , Recombinant Fusion Proteins/toxicity , Species Specificity
4.
Neurology ; 69(4): 356-9, 2007 Jul 24.
Article in English | MEDLINE | ID: mdl-17646627

ABSTRACT

We used an autopsy series to determine whether the newest dementia with Lewy bodies (DLB) consensus pathologic classification correlates with premortem diagnosis of DLB. Neocortical sections from a total of 95 cases with Lewy bodies were stained with alpha-synuclein antibodies. We assigned cases according to the DLB consensus' categories and found a significant association with the premortem clinical diagnosis of DLB. Clinical diagnosis of DLB, however, depended on the presence of low Alzheimer disease pathology (by Braak staging) rather than on Lewy body distribution.


Subject(s)
Brain/pathology , Lewy Bodies/pathology , Lewy Body Disease/classification , Lewy Body Disease/pathology , Neurons/pathology , Alzheimer Disease/pathology , Brain Stem/chemistry , Brain Stem/pathology , Diagnosis, Differential , Humans , Immunohistochemistry , Lewy Bodies/chemistry , Limbic System/chemistry , Limbic System/pathology , Neocortex/chemistry , Neocortex/pathology , Neurons/chemistry , Phenotype , Predictive Value of Tests , alpha-Synuclein/analysis
5.
Neurology ; 67(8): 1486-9, 2006 Oct 24.
Article in English | MEDLINE | ID: mdl-17060582

ABSTRACT

The cellular basis for cognitive deficits in HIV+ patients with and without a history of methamphetamine (METH) use is unclear. We found that HIV+ METH users had more severe loss of interneurons that was associated with cognitive impairment. Compared with other markers, loss of calbindin and parvalbumin interneurons in the frontal cortex was the most significant correlate to memory deficits, suggesting a role in neurobehavioral alterations of HIV+ METH users.


Subject(s)
Amphetamine-Related Disorders/complications , Cognition Disorders/etiology , HIV Seropositivity/complications , Interneurons/pathology , Methamphetamine , Nerve Degeneration/etiology , Nerve Degeneration/pathology , Cadaver , Cognition Disorders/psychology , Frontal Lobe/pathology , Humans , Memory Disorders/etiology , Nerve Degeneration/complications , Severity of Illness Index
6.
Neurology ; 64(1): 129-31, 2005 Jan 11.
Article in English | MEDLINE | ID: mdl-15642916

ABSTRACT

The authors report a patient with Alzheimer disease (AD) without encephalitis who was immunized with AN-1792 (an adjuvanted formulation of Abeta-42). There were no amyloid plaques in the frontal cortex and abundant Abeta-immunoreactive macrophages, but tangles and amyloid angiopathy were present. The white matter appeared normal and minimal lymphocytic infiltration in the leptomeninges was observed. This case illustrates the effects of an Abeta-based immunization on AD pathogenesis in the absence of overt meningoencephalitis and leukoencephalopathy.


Subject(s)
Alzheimer Disease/prevention & control , Amyloid beta-Peptides/therapeutic use , Vaccination/methods , Aged , Alzheimer Disease/pathology , Alzheimer Vaccines/therapeutic use , Autopsy , Brain/pathology , Encephalitis/pathology , Humans , Male , Peptide Fragments/therapeutic use , Vaccination/adverse effects
7.
J Neural Transm (Vienna) ; 112(2): 269-82, 2005 Feb.
Article in English | MEDLINE | ID: mdl-15657642

ABSTRACT

Increased production and reduced clearance of amyloid beta (Abeta) plays a central role in the pathogenesis of Alzheimer's disease (AD). We have recently shown that the neurotrophic peptide mixture Cerebrolysin (Cbl) has the ability of improving synaptic functioning and reducing amyloid deposition in a transgenic (tg) animal model of Alzheimer's disease (AD). Since in AD, potentially toxic Abeta aggregates accumulate not only around neurons but also in the blood vessels, then it is important to investigate whether bioactive compounds such as Cbl might have the capacity to ameliorate the age-related cerebral amyloid angiopathy (CAA) in tg models. To this end, tg mice expressing mutant human amyloid precursor protein (APP) under the Thy1 promoter were treated with Cbl or saline alone starting at 7 or 12 months of age for a total of three months. Neuropathological analysis with an antibody against Abeta showed that Cbl decreased amyloid deposition around the blood vessels in a time dependent manner. These effects were accompanied by a reduction in perivascular microgliosis and astrogliosis and increased expression of markers of vascular fitness such as CD31 and ZO-1. No lymphocytic infiltration was observed associated with Abeta in the vessels. Consistent with these findings, ultrastructural analysis showed that while in tg mice treated with saline alone there was an abundant accumulation of amyloid fibers in the vascular wall accompanied by thickening of the basal membrane and endothelial cell damage, in Cbl-treated mice there was considerable reduction in the subcellular alterations of endothelial and smooth muscle cells with preservation of basal membranes and intercellular junctions. Taken together, these results suggest that Cbl treatment might have beneficial effects in patients with cognitive impairment due to cerebrovascular amyloidosis by reducing Abeta accumulation and promoting the preservation of the cerebrovasculature.


Subject(s)
Alzheimer Disease/drug therapy , Alzheimer Disease/physiopathology , Amino Acids/therapeutic use , Amyloidosis/drug therapy , Brain/blood supply , Brain/drug effects , Amino Acids/pharmacology , Amyloidosis/pathology , Animals , Brain/physiopathology , Cerebrovascular Circulation/drug effects , Cerebrovascular Circulation/physiology , Mice , Mice, Inbred C57BL , Mice, Transgenic , Nerve Growth Factors/pharmacology , Nerve Growth Factors/therapeutic use
8.
J Neural Transm (Vienna) ; 110(11): 1313-27, 2003 Nov.
Article in English | MEDLINE | ID: mdl-14628195

ABSTRACT

Cerebrolysin is a peptide mixture with neurotrophic effects that might have the ability of both reducing amyloid burden and improving synaptic plasticity in Alzheimer's disease (AD). In order to determine if Cerebrolysin is capable of ameliorating the neurodegenerative and behavioral alterations associated with amyloid beta (A beta) production; transgenic (tg) mice expressing mutant human amyloid precursor protein (APP) under the Thy1 promoter were treated with Cerebrolysin or saline alone starting at 3 or 6 months of age for a total of three months. Animals were then tested behaviorally (at 6 and 9 months of age respectively) in the water maze and then analyzed neuropathologically for amyloid burden, synaptic density, astrogliosis and apoptosis. Performance analysis in the water maze showed that in the younger tg mice cohort, Cerebrolysin treatment significantly ameliorated the performance deficits. In the older cohort, there was a trend toward improved performance in the learning curve. Neuropathological examination showed that in both age/treatment groups, Cerebrolysin promoted synaptic regeneration, and reduced the proportion of neurons displaying DNA fragmentation by the (TdT)-mediated dUTP-biotin nick-end labeling (TUNEL) method. Moreover, Cerebrolysin treatment reduced A beta burden by 43% in the young group and by 27% in the older group. Taken together, these results suggest that Cerebrolysin treatment might have beneficial effects in patients with cognitive impairment by reducing A beta accumulation and promoting the preservation of synaptic terminals.


Subject(s)
Alzheimer Disease/drug therapy , Amino Acids/pharmacology , Amyloid beta-Peptides/antagonists & inhibitors , Brain/drug effects , Neuroprotective Agents/pharmacology , Alzheimer Disease/metabolism , Alzheimer Disease/physiopathology , Amyloid beta-Peptides/metabolism , Amyloid beta-Protein Precursor/genetics , Amyloid beta-Protein Precursor/metabolism , Animals , Apoptosis/drug effects , Apoptosis/genetics , Behavior, Animal/drug effects , Behavior, Animal/physiology , Brain/metabolism , Brain/pathology , Disease Models, Animal , Down-Regulation/drug effects , Down-Regulation/genetics , Female , Gliosis/drug therapy , Gliosis/genetics , Gliosis/pathology , Immunohistochemistry , Male , Maze Learning/drug effects , Maze Learning/physiology , Mice , Mice, Transgenic , Neuronal Plasticity/drug effects , Neuronal Plasticity/genetics , Plaque, Amyloid/genetics , Plaque, Amyloid/metabolism , Plaque, Amyloid/pathology , Presynaptic Terminals/drug effects , Presynaptic Terminals/metabolism , Presynaptic Terminals/pathology , Treatment Outcome
9.
Neurology ; 61(2): 206-11, 2003 Jul 22.
Article in English | MEDLINE | ID: mdl-12874400

ABSTRACT

BACKGROUND: The neurodegenerative process in Alzheimer's disease (AD) and in the Lewy body variant of AD (LBV) patients is characterized by cholinergic dysfunction and deposition of amyloid beta-peptide (Abeta) 1-40 and 1-42; however, the differential effects of Abeta species on the cholinergic system are not completely clear. OBJECTIVE: To better understand the relationship between levels of Abeta1-40 and 1-42 on cholinergic deficits in AD and LBV patients. METHODS: Levels of choline acetyltransferase (ChAT) activity and ChAT immunoreactivity in the plaques in the frontal cortex of patients with AD and LBV were correlated with Abeta1-42 and 1-40 levels determined by ELISA and with neuropathologic and neurologic markers. RESULTS: Although the overall levels of ChAT activity were reduced in AD and LBV cases, there was a direct correlation with Abeta1-42 levels. Furthermore, patients with high Abeta1-42 levels had more abundant cholinergic dystrophic neurites in the plaques than cases with lower Abeta1-42. CONCLUSION: Abeta1-42 may also trigger cholinergic dysfunction by promoting aberrant neuritic sprouting.


Subject(s)
Alzheimer Disease/pathology , Amyloid beta-Peptides/physiology , Cholinergic Fibers/pathology , Frontal Lobe/pathology , Lewy Body Disease/pathology , Peptide Fragments/physiology , Aged , Aged, 80 and over , Alzheimer Disease/metabolism , Amyloid beta-Peptides/analysis , Basal Nucleus of Meynert/pathology , Choline O-Acetyltransferase/analysis , Female , Frontal Lobe/chemistry , GAP-43 Protein/analysis , Humans , Lewy Body Disease/metabolism , Male , Nerve Tissue Proteins/analysis , Neurites/ultrastructure , Neurofibrillary Tangles , Neuropsychological Tests , Peptide Fragments/analysis , Plaque, Amyloid/chemistry , Single-Blind Method
10.
Vet Parasitol ; 81(1): 57-68, 1999 Feb 01.
Article in English | MEDLINE | ID: mdl-9950329

ABSTRACT

In order to determine the presence of Trichinella infections in horses slaughtered at an abattoir in Mexico, 147 serum samples were examined by two immunoenzymatic methods. Specific antibodies were detected by ELISA in 7% of the serum samples at a dilution 1:400 and in 10% at lower dilutions (1:20, 1:40) using Trichinella spiralis muscle larvae (ML) excretory/secretory (E/S) products. Serum samples from four naturally infected horses (confirmed by direct methods) gave negative O.D. values in an ELISA at a 1:400 dilution and only two of them were positive at a 1:20 and 1:40 dilutions. Serum samples from experimentally infected horses reacted by Western blotting with ML components with molecular weights of 47, 52, 59, 67, 72 and 105 kDa which correspond to the TSL-1 antigens. Serum samples from the four naturally infected horses and from the abattoir horses that were positive in ELISA using E/S antigens recognized several ML components, some of them reacted with all the TSL-1 antigens mentioned above and others recognized preferentially two or three of these molecules. Since the serologic assays may not offer the sensitivity required in the diagnosis of horses trichinellosis and the direct methods had not always been useful in the detection of larvae in horsemeat related to trichinellosis outbreaks in Europe, it is proposed that additional assays are performed to determine Trichinella infection in horses. These can include detection of parasite antigens by ELISA and Dot ELISA or PCR, which in turn may also help to determine the presence of the parasite in early and late infections of horses.


Subject(s)
Horse Diseases/diagnosis , Trichinella spiralis/isolation & purification , Trichinellosis/veterinary , Abattoirs , Animals , Antibodies, Helminth/blood , Antigens, Helminth/chemistry , Blotting, Western/veterinary , Diaphragm/parasitology , Enzyme-Linked Immunosorbent Assay/veterinary , Female , Horse Diseases/parasitology , Horses , Kinetics , Male , Mexico , Trichinellosis/diagnosis
11.
Rev. méd. IMSS ; 33(3): 341-6, mayo-jun. 1995. ilus
Article in Spanish | LILACS | ID: lil-174156

ABSTRACT

Se realizó un estudio transversal descriptivo, aplicando una encuesta de opiniones sobre el proceso de enseñanza-aprendizaje a 212 médicos egresados de 22 cursos de especialización del Hopsital de Especialidades. Se exploraron aspectos relacionados con el programa académico, estrategias de aprendizaje y evaluación, relaciones humanas y escenario académico. Las estrategias que se consideraron de mayor impacto para su aprendizaje fueron la grupal, tutorial y mixta. Las relaciones interpersonales inadecuadas, fueron señaladas como un obstáculo en el proceso enseñanza-aprendizaje. Consideran que las instalaciones académicas son adecuadas y que la bilioteca debería ampliarse en espacio y horario. Entre las sugerencias más relevantes se encuentran el incremento en el apoyo tutorial y en las actividades en aula, así como un decremento en las cargas de trabajo. Un buen número de alumnos aún encuentran difícil integrarse al sistema activo-participativo, por lo que sería conveniente la planeación y programación de actividades que ayuden al paso gradual de la educación tradicional a la educación activa


Subject(s)
Adult , Middle Aged , Humans , Male , Female , Internship and Residency/trends , Learning/physiology , Education, Medical, Continuing/organization & administration , Teaching/trends , Medicine , Data Collection/methods
SELECTION OF CITATIONS
SEARCH DETAIL
...